|
|
Article: Biolase Announces Global Launch of Endolase RFT Root Canal Therapy System for Waterlase MD Laser System ; First FDA-Cleared Laser for Root Canal Disinfection Is Faster, More Effective Than Conventional Therapy
- Article from:
- CCNMatthews Newswire
- Article date:
- April 10, 2008
CopyrightCopyright 2008 CCNMatthews Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
IRVINE, CA--(Marketwire - April 10, 2008) - BIOLASE Technology,
Inc. (NASDAQ: BLTI), the world's leading dental laser company,
announced today the global launch of its new, minimally invasive
Endolase(TM) RFT Root Canal Therapy System, which enables
endodontists and dentists to perform root canal procedures faster
and more effectively than conventional treatment methods. Endolase
RFT includes two newly designed, single-use laser tips, called
endoTips(TM), and the procedure protocol for use with the Company's
Waterlase(R) MD YSGG laser system. In March of this year, the
Company received U.S. Food and Drug Administration (FDA) 510(k)
clearance of its Waterlase MD with RFT endoTips for root ...